Dr. Yazeed Sawalha
Claim this profileOhio State University Comprehensive Cancer Center
Area of expertise
Non-Hodgkin's Lymphoma
Yazeed Sawalha has run 3 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Diffuse Large B-Cell Lymphoma
Yazeed Sawalha has run 3 trials for Diffuse Large B-Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Ohio State University Comprehensive Cancer Center
Clinical Trials Yazeed Sawalha is currently running
Rituximab vs Mosunetuzumab
for Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. It is not yet known if giving rituximab or mosunetuzumab works better in treating patients with follicular lymphoma with a low tumor burden.
Recruiting
2 awards
Phase 3
13 criteria
Zanubrutinib + R-CHOP
for Diffuse Large B-Cell Lymphoma
This phase Ib trial seeks to find out the best dose and possible side effects and/or benefits of zanubrutinib in combination with the R-PolaCHP in treating patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). Zanubrutinib is designed to block a protein called Bruton Tyrosine Kinase in order to stop cancer growth. R-CHOP is the acronym for the combination of five drugs: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. It is the most widely used chemoimmunotherapy regimen for DLBCL and is considered the standard-of-care treatment for patients with DLBCL. Three of the drugs in R-CHOP (cyclophosphamide, doxorubicin and vincristine) are chemotherapy drugs. Rituximab is a type of immunotherapy and prednisone is a type of steroids.
Recruiting
1 award
Phase 1
More about Yazeed Sawalha
Clinical Trial Related
1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Yazeed Sawalha has experience with
- Rituximab
- Cyclophosphamide
- Prednisone
- Vincristine Sulfate
- Epcoritamab
- Ibrutinib
Breakdown of trials Yazeed Sawalha has run
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma
Follicular Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yazeed Sawalha specialize in?
Yazeed Sawalha focuses on Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Non-Hodgkin's Lymphoma has involved MYC positive patients, or patients who are BCL2 positive.
Is Yazeed Sawalha currently recruiting for clinical trials?
Yes, Yazeed Sawalha is currently recruiting for 3 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Yazeed Sawalha has studied deeply?
Yes, Yazeed Sawalha has studied treatments such as Rituximab, Cyclophosphamide, Prednisone.
What is the best way to schedule an appointment with Yazeed Sawalha?
Apply for one of the trials that Yazeed Sawalha is conducting.
What is the office address of Yazeed Sawalha?
The office of Yazeed Sawalha is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.